卡斯尔生物科技

最新新闻

• 评级变动
  CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/3/3
• 评级变动
  Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $52
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/4/20
• 评级变动
  Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $47
  \u5e02\u573a\u8d44\u8baf · 2026/1/26
• 评级变动
  BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $43
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $57
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/5/29
• 评级变动
  Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $52
  \u5e02\u573a\u8d44\u8baf · 2026/1/14
• 评级变动
  Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/1/30
• 评级变动
  Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $43
  \u5e02\u573a\u8d44\u8baf · 2026/1/5
• 评级变动
  CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2025/12/22
• Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $57
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• Roth MKM Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• 评级变动
  BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44
  \u5e02\u573a\u8d44\u8baf · 2026/8/3

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。